History of cancer diagnosis
Pro Research Analysisby 
Searched over 200M research papers
Evolution of Cancer Diagnosis: Historical and Clinical Perspectives
Increasing Prevalence of Multiple Cancer Diagnoses
With advances in cancer treatment and longer life expectancy, more patients are living long enough to be diagnosed with more than one type of cancer. For example, in a recent study of non-small cell lung cancer (NSCLC) patients, about one in four had a history of another cancer diagnosis, with the most common prior cancers being breast, colon, prostate, and bladder. The median interval since the last cancer diagnosis was over six years, suggesting that many patients with a history of cancer may be suitable for clinical trials, as their risk of recurrence is likely low after such a long follow-up period . Similar findings have been observed in younger lung cancer patients and those with extranodal NK/T-cell lymphoma, where prior cancer history did not significantly impact overall or disease-specific survival, except in certain subgroups or under specific circumstances Liu2020Wang2024.
Family History and Hereditary Cancer Syndromes
Family history has long been recognized as a key factor in cancer risk assessment and diagnosis. Individuals with a pathogenic variant in genes associated with hereditary cancer syndromes, such as BRCA1/2 for breast cancer or MLH1/MSH2/MSH6 for Lynch syndrome, have a higher risk of developing cancer, especially if they also have a first-degree family history of the disease. The risk (penetrance) is notably higher in those with a family history compared to those without, highlighting the importance of considering family history in genetic counseling and follow-up care . Systematic reviews confirm that family history remains a valuable tool for identifying individuals at increased risk, particularly for colorectal cancer, and can influence adherence to recommended screening protocols .
Accuracy and Utility of Family History in Clinical Practice
The accuracy of reported family history varies by cancer type, with higher accuracy for breast and colorectal cancers compared to other types. Verification of family history can sometimes change clinical management, often reducing perceived genetic risk. While full verification is ideal, in practice, reports of certain cancers (like breast cancer) can be relied upon more than others when medical records are unavailable . Implementing structured family history assessment tools in community oncology practices has been shown to increase the identification of patients eligible for genetic testing, especially when family history is included in the evaluation .
The Diagnostic Process in Primary and Pediatric Care
Most cancers are first suspected and diagnosed in primary care settings, where general practitioners must distinguish between benign and malignant causes of common symptoms. This process is complex, as cancer symptoms often overlap with those of non-cancerous conditions. Research has focused on improving the selection of patients for rapid investigation, particularly for common cancers such as breast, lung, colon, and prostate . In pediatric cases, the path to diagnosis can be especially challenging, with parents often noticing vague or non-specific symptoms before a diagnosis is made. Disagreements between parents and healthcare providers about the seriousness of symptoms can lead to delays, underscoring the need for better communication and awareness in both primary and secondary care .
Patient Experiences and Responses to Cancer Diagnosis
Patients' responses to receiving a cancer diagnosis are diverse and shaped by their personal and social contexts. Some experience shock or disbelief, while others find the diagnosis validating or incidental. The way a diagnosis is perceived can influence the clinical encounter and the effectiveness of communication between patients and healthcare providers .
Conclusion
The history of cancer diagnosis is marked by evolving clinical practices, increasing recognition of the importance of family history, and a growing population of patients with multiple cancer diagnoses. Accurate family history assessment, improved diagnostic processes in primary care, and attention to patient experiences all play crucial roles in timely and effective cancer diagnosis and management Campos2024Jackson2022Liu2020+7 MORE.
Sources and full results
Most relevant research papers on this topic
Patients with a history of more than one cancer diagnosis: An opportunity to expand eligibility criteria?
One in four NSCLC patients has a history of other cancer diagnosis, suggesting a significant number may be suitable candidates for clinical trials due to low risk of prior disease recurrence.
Influence of family history on penetrance of hereditary cancers in a population setting
Individuals with pathogenic cancer syndrome variants may have a less elevated risk of cancer without a first-degree family history, highlighting the importance of considering family history in cancer counseling.
Impact of prior cancer history on the overall survival of younger patients with lung cancer
Prior cancer diagnosis has a heterogeneous impact on survival in younger patients with lung cancer, with early-stage patients experiencing adverse survival curves and advanced-stage patients having non-inferior survival.
Accuracy of family history of cancer: clinical genetic implications
Verification of family cancer reports is crucial for clinical genetic diagnosis and management, but breast cancer reports can be limited without significantly compromising medical decision-making.
Family history and the natural history of colorectal cancer: systematic review
Family history of colorectal cancer is a valuable clinical tool for identifying individuals at increased risk for the disease, with higher adherence to colonoscopy screening in those with a family history of CRC.
Cancer diagnosis in primary care.
Primary care diagnosis of common UK cancers like breast, lung, colon, and prostate requires GPs to assess symptoms and determine whether cancer is a possible explanation, despite the presence of benign diseases.
DOI